Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Pacira Bio Sciences, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 172 shares of PCRX stock, worth $4,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172
Previous 172
-0.0%
Holding current value
$4,477
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PCRX
# of Institutions
255Shares Held
48.3MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$208 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$138 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$84.9 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$52.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$51.5 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.19B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...